Literature DB >> 25088004

Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence.

Bernard Vrijens1, John Urquhart, David White.   

Abstract

Nonadherence to prescribed medications can lead to medical complications, disease progression, hospitalizations, overestimated dosing requirements, impaired quality of life, and death, as well as incurring substantive costs for the healthcare system from suboptimal dosing during ambulatory pharmacotherapy. Adherence can be improved by helping patients build habits of taking prescribed medications, impacting day-to-day implementation of and persistence with rationally prescribed drug dosing regimens. Accurate, easily understood and personally relevant feedback is clearly relevant to many patients in this process. There is a clear-cut need for studies specifically designed to investigate interventions aimed at improving adherence, taking into account the sometimes complex nature of these interventions. Implementation of results from such studies can be expected to improve outcomes. For scientific progress to be maintained in this field, there is also a clear need for consistent use of a sound taxonomy for the dosing errors that comprise poor adherence (distinguishing between initiation, implementation and discontinuation), and for interventions performed to improve adherence.

Entities:  

Keywords:  adherence; behavioral change; clinical pharmacology; habit; implementation; intervention; taxonomy

Mesh:

Substances:

Year:  2014        PMID: 25088004     DOI: 10.1586/17512433.2014.940896

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  16 in total

Review 1.  Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy.

Authors:  Kate M Bell; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2018-10       Impact factor: 5.071

Review 2.  Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.

Authors:  Jennifer S Gewandter; Robert H Dworkin; Dennis C Turk; Eric G Devine; David Hewitt; Mark P Jensen; Nathaniel P Katz; Amy A Kirkwood; Richard Malamut; John D Markman; Bernard Vrijens; Laurie Burke; James N Campbell; Daniel B Carr; Philip G Conaghan; Penney Cowan; Mittie K Doyle; Robert R Edwards; Scott R Evans; John T Farrar; Roy Freeman; Ian Gilron; Dean Juge; Robert D Kerns; Ernest A Kopecky; Michael P McDermott; Gwendolyn Niebler; Kushang V Patel; Richard Rauck; Andrew S C Rice; Michael Rowbotham; Nelson E Sessler; Lee S Simon; Neil Singla; Vladimir Skljarevski; Tina Tockarshewsky; Geertrui F Vanhove; Ajay D Wasan; James Witter
Journal:  J Pain       Date:  2019-12-13       Impact factor: 5.820

Review 3.  Successful withdrawal from high-dose benzodiazepine in a young patient through electronic monitoring of polypharmacy: a case report in an ambulatory setting.

Authors:  Hèctor R Loscertales; Valerie Wentzky; Kenneth Dürsteler; Johannes Strasser; Kurt E Hersberger; Isabelle Arnet
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-24

4.  Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations.

Authors:  Jennifer S Gewandter; Shannon M Smith; Robert H Dworkin; Dennis C Turk; Tong J Gan; Ian Gilron; Sharon Hertz; Nathaniel P Katz; John D Markman; Srinivasa N Raja; Michael C Rowbotham; Brett R Stacey; Eric C Strain; Denham S Ward; John T Farrar; Kurt Kroenke; James P Rathmell; Richard Rauck; Colville Brown; Penney Cowan; Robert R Edwards; James C Eisenach; McKenzie Ferguson; Roy Freeman; Roy Gray; Kathryn Giblin; Hanna Grol-Prokopczyk; Jennifer Haythornthwaite; Robert N Jamison; Marc Martel; Ewan McNicol; Michael L Oshinsky; Friedhelm Sandbrink; Joachim Scholz; Richard Scranton; Lee S Simon; Deborah Steiner; Kenneth Verburg; Ajay D Wasan; Kerry Wentworth
Journal:  Pain       Date:  2021-11-01       Impact factor: 7.926

5.  Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.

Authors:  Xiaoqiu Liu; James J Lewis; Hui Zhang; Wei Lu; Shun Zhang; Guilan Zheng; Liqiong Bai; Jun Li; Xue Li; Hongguang Chen; Mingming Liu; Rong Chen; Junying Chi; Jian Lu; Shitong Huan; Shiming Cheng; Lixia Wang; Shiwen Jiang; Daniel P Chin; Katherine L Fielding
Journal:  PLoS Med       Date:  2015-09-15       Impact factor: 11.069

Review 6.  Current Situation of Medication Adherence in Hypertension.

Authors:  Bernard Vrijens; Sotiris Antoniou; Michel Burnier; Alejandro de la Sierra; Massimo Volpe
Journal:  Front Pharmacol       Date:  2017-03-01       Impact factor: 5.810

7.  Group-Based Trajectory Models: Assessing Adherence to Antihypertensive Medication in Older Adults in a Community Pharmacy Setting.

Authors:  Paul Dillon; Derek Stewart; Susan M Smith; Paul Gallagher; Gráinne Cousins
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

8.  Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest Ethiopia: a randomised controlled trial.

Authors:  Kassahun Dessie Gashu; Kassahun Alemu Gelaye; Richard Lester; Binyam Tilahun
Journal:  BMJ Health Care Inform       Date:  2021-06

9.  Digital health for the End TB Strategy: developing priority products and making them work.

Authors:  Dennis Falzon; Hazim Timimi; Pascal Kurosinski; Giovanni Battista Migliori; Wayne Van Gemert; Claudia Denkinger; Chris Isaacs; Alistair Story; Richard S Garfein; Luis Gustavo do Valle Bastos; Mohammed A Yassin; Valiantsin Rusovich; Alena Skrahina; Le Van Hoi; Tobias Broger; Ibrahim Abubakar; Andrew Hayward; Bruce V Thomas; Zelalem Temesgen; Subhi Quraishi; Dalene von Delft; Ernesto Jaramillo; Karin Weyer; Mario C Raviglione
Journal:  Eur Respir J       Date:  2016-05-26       Impact factor: 16.671

10.  Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.

Authors:  Jessica E Haberer; Lora Sabin; K Rivet Amico; Catherine Orrell; Omar Galárraga; Alexander C Tsai; Rachel C Vreeman; Ira Wilson; Nadia A Sam-Agudu; Terrence F Blaschke; Bernard Vrijens; Claude A Mellins; Robert H Remien; Sheri D Weiser; Elizabeth Lowenthal; Michael J Stirratt; Papa Salif Sow; Bruce Thomas; Nathan Ford; Edward Mills; Richard Lester; Jean B Nachega; Bosco Mwebesa Bwana; Fred Ssewamala; Lawrence Mbuagbaw; Paula Munderi; Elvin Geng; David R Bangsberg
Journal:  J Int AIDS Soc       Date:  2017-03-22       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.